National Scene

S. 2554: Patient Right to Know Drug Prices Act

*Much of the piece is excerpted from Gov.Track 

Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when they would cost less out of pocket. Yet pharmacists are often under gag orders from telling customers about that discrepancy.

A new bill introduced in the Senate would end this practice.


A “pharmacy gag clause” is a tactic under which a pharmacist may not inform customers which of the two options would cost less for a certain product: using their health insurance or paying fully out of pocket.

These clauses are usually instituted by an insurer or pharmacy benefit manager (PBM), the most famous of which include CVS Health, Express Scripts, or United Health. They’re put in for cases in which most consumers would save money by paying out of pocket — if only they knew. Pharmacy benefit managers pocket the difference.

States are increasingly banning the practice, including three in March alone: Mississippi, South Dakota, and Virginia. The total is now 14 states, from red states like the ones mentioned above to blue states like Minnesota and Connecticut.

What the bill does:

Since there is no such law to prevent cost transparency Senator Susan Collins (R-ME) has introduced S.2554; the Know the Lowest Price Act would ban the practice of pharmacy gag clauses.

Supporters argue the legislation would ensure full transparency when consumers make purchasing decisions, as they do with nutrition facts on food and drink products.

“Multiple reports have exposed how this egregious practice has harmed consumers, such as one customer who used his insurance to pay $129 for a drug when he could have paid $18 out of pocket,” Senate lead sponsor Collins said in a press release.

“Americans have the right to know which payment method — insurance or cash — would provide the most savings when purchasing prescription drugs,” Collins continued. “By prohibiting gag clauses, our legislation would take concrete action to lower the cost of prescription drugs, saving consumers money.”

Opponents are essentially entirely within the industries of health insurance or pharmacy benefit managers, such as CVS Health, Express Scripts, or United Health.

“Pharmacy benefit managers (PBMs) typically reduce prescription drug costs by 30 percent for more than 266 million Americans enrolled in private and public plans, most notably Medicare Part D,” the Pharmaceutical Care Management Association said in a statement to NBC Chicago.

“PBMs use their substantial scale and expertise to negotiate aggressive rebates, discounts, and other price concessions from drug manufacturers and drugstores on prescription drugs,” the statement continued. “We support the patient paying the lowest price available at the pharmacy counter for the prescribed drug.”

As for the White House’s position,President Trump’s Secretary of Health and Human Services Alex Azar has indicated a willingness to take the problem on.

There is a grand opportunity at this moment with the promotion of HSA accounts and efforts to re-introduce a market based health care system to demand transparency, access, competitive pricing and use of cash. 

The bill has attracted four bipartisan Senate cosponsors: two Republicans and two Democrats. None are from Pennsylvania. Should both Senator Toomey and Senator Casey be co-sponsoring this legislation? Let them know. 

Senator Toomey (202) 224-4254

Senator Casey (202) 224-6324